# 04_QA_REPORT --- PP-0200 D1 Lymphadenectomy

## QA Metadata

  Field                 Value
  --------------------- ---------------------------------------------------
  PP ID                 PP-0200
  Title                 D1 Lymphadenectomy
  QA Version            1.0.0
  Artifact Version      1.0.0
  Decision Status       APPROVED / LOCKED
  QA Standard           FREEZE GOLD POPULATION PACKAGE SPECIFICATION v1.1
  Governance Standard   CORE_WORKING_RULES v1.7
  Evidence Basis        Project Source Files
  Final Decision        PASS

## 1. Scope QA

### Requirement

The package must answer one atomic clinical educational question and
must not duplicate substantive ownership of adjacent PPs.

### Verification

**PASS**

The package is restricted to D1 lymphadenectomy.

It does not redefine the general lymphadenectomy package, does not
become a D2 package, and does not become a sentinel-node package.

### Scope ownership

  Topic                          PP-0200 Ownership
  ------------------------------ -------------------------------
  General lymphadenectomy        Introduced only; PP-0199 owns
  D1 definition                  Core
  D1 regional field              Core
  D1 station-based groups 1--7   Core, source-attributed
  D1+                            Supporting/boundary
  D2                             Comparative/boundary only
  Sentinel lymph node            Excluded/delegated
  EMR/ESD                        Boundary only
  Gastrectomy                    Prerequisite/context
  Pathology                      Interface only
  Systemic treatment             Excluded

## 2. Boundary QA

### Required clean boundary

**Core =** D1-specific anatomical extent, regional/perigastric nodal
territory, supplied station-based classification, D1+ comparison,
selected clinical context, node-yield distinction, staging interface,
patient interpretation.

**Supporting =** D1/D2 comparison, regional practice differences,
surgical expertise, minimally invasive context, organ-preservation
principles, historical comparative evidence.

**Explicitly Excluded =** detailed D2, sentinel-node methodology,
endoscopic technique, operative steps, detailed pathology, systemic
therapy, individualized recommendations.

**Delegated-to PP =** PP-0199, PP-0193--0198, PP-0201, PP-0202, and
downstream treatment packages.

**Result: PASS**

## 3. Clinical Evidence QA

### Source-first verification

The package was produced after searching the project Source Files.

Primary evidence identified:

1.  NCCN Gastric Cancer v2.2026.
2.  Vietnamese gastric-cancer diagnosis/treatment guideline.

Supporting evidence identified:

3.  ACS Stomach Cancer.
4.  NCI Gastric Cancer Treatment PDQ.

**Result: PASS**

## 4. Clinical Definition QA

### D1 definition

The package uses the current NCCN anatomical definition as the primary
anchor.

**PASS**

### D1 station framework

The package states that the supplied Vietnamese guideline describes D1
as groups 1--7.

**PASS**

### D2 distinction

The package correctly treats D2 as a broader extent and delegates
detailed D2 content to PP-0201.

**PASS**

### D1+ distinction

The package describes D1+ as an extension rather than as a separate
unrelated concept.

**PASS**

## 5. Node-Count QA

### Critical rule

The package must not equate D1 with a fixed node count.

### Verification

The package explicitly states:

**D1 = anatomical extent**

and

**≥16 = node-examination goal**

It further distinguishes:

-   nodes removed;
-   nodes examined;
-   nodes positive.

**Result: PASS**

This is a high-priority clinical safety and knowledge-integrity check.

## 6. Early Gastric Cancer QA

The package states that selected Tis/T1a lesions may be candidates for
EMR/ESD according to the current NCCN source.

It does not state that all early gastric cancers require D1.

**Result: PASS**

## 7. Organ-Preservation QA

The package does not imply routine splenectomy or pancreatectomy.

It explicitly preserves the NCCN principle that routine splenectomy is
not indicated unless a specific clinical reason exists.

**Result: PASS**

## 8. Palliative-Surgery QA

The package states that palliative gastric resection does not
necessarily include lymph-node dissection.

It therefore does not incorrectly universalize D1 to all gastric-cancer
surgery.

**Result: PASS**

## 9. Comparative Evidence QA

The package discusses D1 versus D2 only to explain the clinical
boundary.

It avoids:

-   "D2 is always better."
-   "D1 is always safer."
-   "D1 is obsolete."

The NCCN historical trial context is described as context-dependent.

**Result: PASS**

## 10. Patient-Safety QA

The package does not:

-   diagnose a patient;
-   select a surgical procedure for an individual;
-   prescribe treatment;
-   provide operative instructions;
-   give individualized prognosis;
-   instruct the patient to change therapy.

**Result: PASS**

## 11. Educational QA

### Plain language

Medical terms are explained.

**PASS**

### One concept per paragraph

The CKO uses short, focused sections and paragraphs.

**PASS**

### Patient-facing usability

The package contains:

-   patient explanation;
-   key messages;
-   misconceptions;
-   questions to ask the clinical team.

**PASS**

### Neutral tone

No sensational or coercive language.

**PASS**

## 12. Evidence Traceability QA

Every major clinical concept is mapped to a project Source File.

  Claim Domain                   Source
  ------------------------------ ----------------------
  D1 anatomical definition       NCCN
  D1/D2 distinction              NCCN
  D1 station groups 1--7         Vietnamese guideline
  ≥16-node goal                  NCCN
  Early endoscopic alternative   NCCN
  Regional lymphadenectomy       NCCN/NCI
  Surgeon experience             ACS/NCCN
  Palliative surgery             NCCN/ACS
  Nodal staging interface        NCI
  D1/D2 historical comparison    NCCN

**Result: PASS**

## 13. Unsupported-Claim QA

The following claims were intentionally rejected:

-   D1 always equals exactly 16 nodes.
-   D1 is always superior to D2.
-   D2 is always superior to D1.
-   Every early gastric cancer requires D1.
-   D1 guarantees cure.
-   D1 requires routine splenectomy.
-   A node count alone identifies surgical extent.

**Result: PASS**

## 14. Knowledge Graph QA

### Prerequisites

-   PP-0196
-   PP-0197
-   PP-0198
-   PP-0199

### Related

-   PP-0193
-   PP-0194
-   PP-0195
-   PP-0201
-   PP-0202

### Next

-   PP-0201

The graph is coherent with the supplied Registry.

**Result: PASS**

## 15. Artifact Structure QA

Required artifacts:

-   01_CKO.md
-   02_KNOWLEDGE_PASSPORT.md
-   03_PRIMARY_EVIDENCE_PACKAGE.md
-   04_QA_REPORT.md

**Result: PASS**

## 16. Gold Depth QA

The governing specification states that future packages must not be
compacted below approved Gold references.

The four artifacts include:

-   extensive clinical knowledge blocks;
-   explicit scope;
-   detailed evidence classification;
-   evidence matrix;
-   clinical evidence interpretation;
-   knowledge graph;
-   patient-facing explanation;
-   misconception handling;
-   runtime safety rules;
-   multi-layer QA;
-   traceability;
-   future update triggers.

**Result: PASS**

## 17. Governance QA

The package follows:

-   Source-First Rule.
-   Approved Decision Batch.
-   Gold artifact specification.
-   Explicit boundary.
-   Adjacent-package overlap control.
-   Four-artifact production rule.
-   Semantic versioning.
-   Repository-ready naming.

**Result: PASS**

## 18. Final Quality Decision

# PASS

PP-0200 satisfies the locked Gold production requirements and the
approved/locked PP-0200 Decision Batch.

The package preserves the central conceptual safeguard:

> **D1 is an anatomical lymphadenectomy extent; lymph-node count is a
> separate pathological/staging measurement.**

The package also preserves the architecture:

**PP-0199 --- Lymphadenectomy**

↓

**PP-0200 --- D1 Lymphadenectomy**

↓

**PP-0201 --- D2 Lymphadenectomy**

↓

**PP-0202 --- Sentinel Lymph Node**

No substantive ownership conflict was identified.

## Final Status

**QA final status: PASS --- GOLD --- READY FOR INTEGRATION.**

# Extended QA Evidence

## 19. Cross-Artifact Consistency

### CKO versus KP

The CKO defines D1 as the package's core clinical concept.

The KP identifies the same concept and does not introduce a competing
scope.

**PASS**

### CKO versus Evidence Package

The Evidence Package supports the CKO's principal claims.

No major CKO claim is left without a source category.

**PASS**

### Evidence Package versus QA

The QA report evaluates the exact scope and evidence claims described in
the Evidence Package.

**PASS**

### Boundary consistency

The same Core / Supporting / Explicitly Excluded / Delegated structure
is preserved.

**PASS**

## 20. Source-Fidelity QA

### NCCN

The package preserves:

-   D1 anatomical definition;
-   D2 extension;
-   ≥16-node goal;
-   selected endoscopic context;
-   splenectomy principle;
-   palliative context.

**PASS**

### Vietnamese guideline

The package preserves the supplied station-based D1 framework and does
not silently replace it with invented terminology.

**PASS**

### NCI

The package uses NCI only for supported regional lymphadenectomy and
nodal-staging context.

**PASS**

### ACS

The package uses ACS for patient-facing context and surgeon/hospital
experience.

The simplified ACS D1/node-count wording is explicitly reconciled rather
than copied as the governing definition.

**PASS**

## 21. Claim Calibration QA

Each major claim is assigned one of:

-   Established / guideline-supported;
-   Supported but context-dependent;
-   Not established / prohibited.

This prevents emerging or context-specific evidence from being converted
into universal clinical advice.

**PASS**

## 22. Boundary Leakage QA

Potential leakage areas were reviewed.

### D2

Only comparative material remains.

**PASS**

### Sentinel lymph node

No substantive methodology included.

**PASS**

### EMR/ESD

Only the relationship to avoiding surgical lymphadenectomy is discussed.

**PASS**

### Gastrectomy

No duplicate detailed subtotal/total gastrectomy content.

**PASS**

### Pathology

Only the node-count/staging interface is covered.

**PASS**

### Systemic therapy

Excluded.

**PASS**

## 23. Patient-Facing Safety QA

The package avoids statements that could cause a patient to:

-   choose a surgical extent independently;
-   assume a node count proves D1 or D2;
-   assume negative nodes guarantee cure;
-   assume splenectomy is routine;
-   assume D1 is universally appropriate.

**PASS**

## 24. Clinical Ambiguity QA

### Ambiguity: D1 versus 16 nodes

Resolved by explicit distinction.

**PASS**

### Ambiguity: D1 versus D1+

Resolved through extension framework.

**PASS**

### Ambiguity: D1 versus D2

Resolved through anatomical comparison and delegation.

**PASS**

### Ambiguity: early gastric cancer

Resolved by separating endoscopic candidates from surgical pathways.

**PASS**

### Ambiguity: palliative surgery

Resolved by distinguishing curative oncologic surgery from
symptom-directed surgery.

**PASS**

## 25. Knowledge Graph QA

The graph is:

**PP-0199 Lymphadenectomy**

↓

**PP-0200 D1 Lymphadenectomy**

↓

**PP-0201 D2 Lymphadenectomy**

↓

**PP-0202 Sentinel Lymph Node**

with upstream gastrectomy packages and adjacent endoscopic packages.

This preserves a coherent hierarchy without assigning D2 or
sentinel-node ownership to PP-0200.

**PASS**

## 26. Versioning QA

All four artifacts use version:

**1.0.0**

The ZIP name includes:

-   PP number;
-   full title;
-   GOLD status;
-   semantic version.

**PASS**

## 27. Repository QA

Expected repository structure:

``` text
PP-0200_D1_Lymphadenectomy_GOLD_v1.0.0/
├── 01_CKO.md
├── 02_KNOWLEDGE_PASSPORT.md
├── 03_PRIMARY_EVIDENCE_PACKAGE.md
└── 04_QA_REPORT.md
```

**PASS**

## 28. Gold Depth QA --- Detailed Review

### CKO

Includes:

-   metadata;
-   educational objectives;
-   scope;
-   boundary;
-   50+ clinical knowledge concepts;
-   patient-facing explanations;
-   misconceptions;
-   runtime patterns;
-   knowledge graph;
-   revision history.

**PASS**

### Knowledge Passport

Includes:

-   identity;
-   classification;
-   runtime metadata;
-   retrieval tags;
-   evidence hierarchy;
-   safety rules;
-   evidence limitations;
-   update logic;
-   integration notes.

**PASS**

### Primary Evidence Package

Includes:

-   clinical question;
-   scope;
-   primary sources;
-   supporting sources;
-   evidence hierarchy;
-   claim-level matrix;
-   evidence interpretation;
-   reconciliation rules;
-   evidence quality;
-   comparative context;
-   evidence gaps;
-   future update triggers;
-   traceability summary.

**PASS**

### QA Report

Includes:

-   scope QA;
-   boundary QA;
-   source fidelity;
-   claim calibration;
-   clinical definition;
-   node-count safeguards;
-   early cancer QA;
-   organ preservation;
-   palliative context;
-   comparative evidence;
-   patient safety;
-   educational QA;
-   traceability;
-   governance;
-   versioning;
-   repository readiness.

**PASS**

## 29. Gold Depth Integrity Statement

The package was deliberately expanded to preserve the project's
non-negotiable Gold Depth Rule.

It is not a compact summary.

The four artifacts are designed as reusable governed knowledge assets
rather than as four short notes.

**PASS**

## 30. Evidence Traceability QA

The following high-priority claims have explicit source ownership:

  -----------------------------------------------------------------------
  Claim                   Source                  Traceability
  ----------------------- ----------------------- -----------------------
  D1 anatomical           NCCN                    Direct
  definition                                      

  D1 regional/perigastric NCCN                    Direct
  field                                           

  D1 groups 1--7          Vietnamese guideline    Direct within source
                                                  framework

  D1+                     Vietnamese guideline    Direct within source
                                                  framework

  D2 extension            NCCN                    Direct

  ≥16-node goal           NCCN                    Direct

  EMR/ESD context         NCCN                    Direct

  Nodal staging           NCI                     Direct

  Surgeon experience      ACS                     Direct

  Palliative              NCCN                    Direct
  lymphadenectomy                                 
  distinction                                     

  Routine splenectomy not NCCN                    Direct
  indicated                                       
  -----------------------------------------------------------------------

**PASS**

## 31. Contradiction QA

No unresolved contradiction remains within the package.

The only potentially confusing source difference is the simplified ACS
description of D1 in relation to 16 nodes.

The package explicitly reconciles this by using the current NCCN
anatomical definition as the governing definition.

**PASS**

## 32. Overclaim QA

The following overclaims are explicitly excluded:

-   "D1 is always enough."
-   "D1 is obsolete."
-   "D2 is always better."
-   "D1 is always safer."
-   "16 nodes defines D1."
-   "Negative nodes mean cure."
-   "D1 prevents recurrence."
-   "D1 requires spleen removal."
-   "All early cancers require D1."

**PASS**

## 33. Medical-AI Runtime QA

The package supports safe retrieval because:

1.  definitions are explicit;
2.  source hierarchy is explicit;
3.  uncertainty is explicit;
4.  boundaries are explicit;
5.  individualized advice is prohibited;
6.  common misconceptions are encoded;
7.  downstream routing is encoded.

**PASS**

## 34. Maintainability QA

The package identifies update triggers.

This allows future guideline changes to be detected without rewriting
the whole architecture.

**PASS**

## 35. Integration Readiness QA

The package contains the required four governed artifacts.

No missing artifact identified.

No unresolved architecture blocker identified.

No unsupported clinical expansion identified.

**PASS**

## 36. Final Quality Decision

# PASS

PP-0200 satisfies the locked Gold production standard.

The package is clinically bounded, source-grounded, patient-centered,
traceable, and reusable.

The most important integrity safeguard is preserved:

> **Anatomical lymphadenectomy extent, lymph nodes examined, and lymph
> nodes positive are three related but distinct concepts.**

The package also preserves the intended knowledge-graph ownership:

**General lymphadenectomy**

↓

**D1**

↓

**D2**

↓

**Sentinel lymph node**

No substantive ownership conflict was identified.

## Final Status

**QA final status: PASS --- GOLD --- READY FOR INTEGRATION.**
